JPMorgan Raises Apple Price Target to $315 Ahead of Earnings
JPMorgan lifts Apple price target to $315, citing strong iPhone 17 demand despite higher memory costs, and maintains an Overweight rating.
JPMorgan lifts Apple price target to $315, citing strong iPhone 17 demand despite higher memory costs, and maintains an Overweight rating.
Needham upgrades AppLovin to Buy, raising its price target to $700 and boosting 2026 e-commerce revenue forecasts due to stronger advertiser growth.
Oppenheimer upgrades Relay Therapeutics to Outperform, citing potential upside from competitor trial risks and upcoming VIKTORIA-1 results.
MannKind (MNKD) receives FDA approval for updated Afrezza dosing recommendations, making it easier for patients to switch from insulin injections to inhaled insulin therapy.
SkyWater Technology stock surges 6% as IonQ announces $35/share acquisition creating first vertically integrated quantum platform company worth $1.8 billion.
Baker Hughes reports 11% profit increase in Q4 2025 as gas technology equipment demand offsets weakness in oilfield services business.